Prevention Without Infrastructure Is Just Hope

Why prevention keeps failing in systems built to treat, not to prevent

Prevention appears in every mission statement, anchors every strategic plan and shows up at every conference panel. In virtually every health system in this country, it is among the first things praised and among the last things actually built. Unfortunately, that gap is not accidental, and it is not closing.

Prevention does not fail because we do not believe in it, but because belief is not infrastructure. Values do not create outcomes, design does. We have spent decades expecting prevention to happen inside workflows built for acute visits, payment models built around intervention, staffing structures already stretched thin, and data systems far better at documenting what happened than identifying what should happen next.

In the last issue, I wrote about how systems produce exactly what they are designed to produce. The follow-up question is whether prevention has an actual structure behind it to succeed, or whether we are still expecting it to emerge organically from a system that was never built to deliver it.

A prevention strategy does not materialize and become real just because a health system says it matters. These systems only become a reality when someone owns it and puts the infrastructure in place to support it.  It requires not only a defined workflow, but also a reimbursement model, a staffing plan, a tracking mechanism, and longitudinal accountability behind it. Without that, prevention is not strategy, it is aspiration, and aspiration does not scale.

As physicians, we see this daily. Missed follow-up after abnormal findings, patients who fall through the cracks between screening, diagnosis, and treatment. Meanwhile, clinicians are expected to absorb prevention on top of workloads that are already unsustainable with no reimbursement, and also fight misinformation while external bad actors vilify preventative care interventions like vaccinations.

Primary care physicians carry the heaviest share of this burden. They are the front line of prevention in theory- the longitudinal relationship, the earliest clinical touchpoint before disease takes hold. In practice, they are being asked to own prevention within panel sizes, visit structures, and reimbursement models that were never built to support it. A 15-minute visit is not a prevention system. A quality metric checkbox is not longitudinal care. And a physician stretched across 20+ patients a day is also being asked to counteract the erosion of trust in preventive interventions — vaccines, screenings, evidence-based care — by external actors who have made that work harder and more time-consuming than it has ever been. What we get instead is individual heroics: the thoughtful physician who remembers to follow up, the navigator who catches what no one else had time to see, the patient persistent enough to keep calling. That is not a prevention system. It is a patchwork of good intentions compensating for structural absence. And good intentions are not a substitute for architecture.

There are some fundamental questions that need to be addressed if we are going to strategically and systemically update the system to prioritize prevention. Who owns prevention in this system? Who is accountable for follow-through? What happens after risk is identified? Where does that work live, and who gets time to do it? How is it funded and compensated? What metric tells us whether it is working,  and what happens when it is not? These are not philosophical questions, they are design questions. Too often, they are the questions no one has answered.

And that last question is harder than it sounds. Prevention succeeds when nothing happens,  when the cancer is caught early enough to cure, when the hospitalization is avoided, when the vaccine prevents an illness, when an intervention was never needed. You cannot point to the disease that did not develop. You cannot put an absence on a dashboard. This is part of why prevention gets under-resourced: the ROI is real, but it is invisible in the ways health systems are built to measure.

Consider what we would never accept elsewhere. No health system would expect an ICU to function without workflows, staffing models, and clear escalation protocols. No surgical service would run on vague encouragement and no cancer center would assume that good intentions are enough to move patients safely through diagnosis, treatment, and follow-up. And yet prevention is routinely approached exactly that way; diffuse, under-resourced, functionally ownerless.

This is ultimately a leadership question.

If prevention is truly a priority, it has to be visible in the architecture of the organization. In budget decisions, staffing decisions, workflow design, quality metrics, technology investments, and lines of accountability. Not just in the values statement or as a talking point.  The harder question for leaders is not whether they support prevention in principle. Most do, but it is whether their organization has actually built the conditions under which prevention can succeed.

Does prevention have an operational home? Does it have a business model? Does it have longitudinal accountability? Does it integrate meaningfully across primary care, specialty care, diagnostics, navigation, and follow-up? Or are we still asking already overextended clinicians to carry it on the margins of a system built for something else?

A system built for episodic intervention will not accidentally become a prevention system, it must be designed into one. And that design is not abstract, it is visible in what gets funded, what gets measured, what gets rewarded, and what gets owned.

This matters across cancer, cardiovascular disease, maternal health, mental health, every area where earlier risk recognition and longitudinal action can change outcomes. We know prevention alters trajectories and we know earlier intervention reduces human suffering and downstream cost.

The problem has never been a lack of evidence that prevention matters. The problem is that evidence alone does not build infrastructure. Leadership does.

So when organizations talk about moving upstream, reducing avoidable illness, improving outcomes, building healthier communities. The most important question is no longer whether they believe in prevention. It is whether they have built for it.  Because prevention without infrastructure is just hope. And hope, while powerful, is not an operating model.

Before the Next Issue

Issue 4 takes this further. Because if prevention requires infrastructure, trust does too. We often treat trust as emotional or cultural,  but in healthcare, trust is also shaped by design: by access, communication, transparency, continuity, and whether the system repeatedly gives people a reason to believe it will show up for them. We have seen that trust erode and rebuilding a better healthcare system means rebuilding trust  too.

Before then, one question:

What is one area in your organization where prevention is treated as important in principle but unsupported in practice?

Reply and tell me. I read every one.


This issue of Designing Modern Healthcare was first published on LinkedIn. Read and comment on the original, or subscribe to the newsletter.

About Shikha Jain, MD FACP

Dr. Shikha Jain, MD, FACP, is a triple board-certified hematologist-oncologist and tenured Associate Professor of Medicine at the University of Illinois Chicago, specializing in gastrointestinal cancers and neuroendocrine tumors. She is the Founder and Board Chair of Women in Medicine®, host of Healio's Oncology Overdrive podcast, and a national voice on healthcare delivery, physician leadership, and gender equity.

Leave a Comment